Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Plos Medicine
|
October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
Tesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Malaria Journal
|
June 6, 2026
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis
Tamiru Shibiru Degaga, Kamala Thriemer, Megha Rajasekhar, et al.
Plos Medicine
|
May 17, 2017
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
Tesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
The Lancet. Infectious Diseases
|
September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Megha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Nature Medicine
|
October 26, 2023
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa
Tadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
The Lancet. Microbe
|
June 8, 2026
Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial
Migbaru Keffale Bezabih, Tadesse Misganaw, Legesse Alamerie Ejigu, et al.
The Lancet. Infectious Diseases
|
September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine
|
October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Robert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Malaria Journal
|
October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Parinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
The Lancet. Child & Adolescent Health
|
September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Plos Medicine
|
October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
Tesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Malaria Journal
|
June 6, 2026
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis
Tamiru Shibiru Degaga, Kamala Thriemer, Megha Rajasekhar, et al.
Plos Medicine
|
May 17, 2017
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
Tesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
The Lancet. Infectious Diseases
|
September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Megha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Nature Medicine
|
October 26, 2023
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa
Tadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
The Lancet. Microbe
|
June 8, 2026
Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial
Migbaru Keffale Bezabih, Tadesse Misganaw, Legesse Alamerie Ejigu, et al.
The Lancet. Infectious Diseases
|
September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine
|
October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Robert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Malaria Journal
|
October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Parinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
The Lancet. Child & Adolescent Health
|
September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Page
of 9